Small Generic Pharmaceuticals Company for Sale in Godhra, India
Underutilized pharmaceutical manufacturing unit with antibiotic and beta-lactam portfolio, licensed, offering strong revival potential.
| Established | 10-20 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 21 thousand |
| Run Rate Sales | USD 12.6 thousand |
| EBITDA Margin | Nil |
| Industries | Generic Pharmaceuticals |
| Locations | Godhra |
| Local Time | 11:32 PM Asia / Kolkata |
| Listed By | Management Member |
| Status | Active |
Full Sale
Asking Price:
USD
900 thousand
(Native Currency: INR 85,000,000)
Reason: The promoter is retiring.
Includes physical assets worth
USD
900 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview
• Owned a pharmaceutical formulation manufacturing unit specializing in antibiotics and beta-lactam products.
• Manufactures tablets, capsules, and dry syrups under regulated pharmaceutical standards.
• Product portfolio includes approximately 40 SKUs across therapeutic categories.
• Produces formulations under its own brand through an established distributor network.
• Also undertakes third-party/job work manufacturing for external pharma companies.
• Installed tablet manufacturing capacity of around 1.5 crore tablets per month per shift.
• Capsule manufacturing capacity of approximately 50 lakh capsules per month per shift.
• Dry syrup production capacity of about 40,000–50,000 bottles per month per shift.
• Currently operating at around 5% capacity utilization, leaving substantial headroom for scale-up.
• Business activity has reduced over the past two years due to promoter health and age-related constraints.
• Sales decline attributed to operational slowdown rather than market or regulatory issues.
• Holds valid drug manufacturing license for regulated formulations.
• Registered under GST and MSME, ensuring statutory and compliance readiness. Does not have USFDA approval.
• Suitable for revival through professional management, marketing tie-ups, or strategic investment.
• Manufactures tablets, capsules, and dry syrups under regulated pharmaceutical standards.
• Product portfolio includes approximately 40 SKUs across therapeutic categories.
• Produces formulations under its own brand through an established distributor network.
• Also undertakes third-party/job work manufacturing for external pharma companies.
• Installed tablet manufacturing capacity of around 1.5 crore tablets per month per shift.
• Capsule manufacturing capacity of approximately 50 lakh capsules per month per shift.
• Dry syrup production capacity of about 40,000–50,000 bottles per month per shift.
• Currently operating at around 5% capacity utilization, leaving substantial headroom for scale-up.
• Business activity has reduced over the past two years due to promoter health and age-related constraints.
• Sales decline attributed to operational slowdown rather than market or regulatory issues.
• Holds valid drug manufacturing license for regulated formulations.
• Registered under GST and MSME, ensuring statutory and compliance readiness. Does not have USFDA approval.
• Suitable for revival through professional management, marketing tie-ups, or strategic investment.
Products & Services Overview
Antibiotic and beta-lactam tablets, capsules, and dry syrups sold under own brand via distributors and through third-party manufacturing contracts.
Assets Overview
Tangible assets:- Land- INR 7 cr.
- Building, infrastructure, and machinery - INR 1.5 cr.
Facilities Overview
- Owned premises.- Land area - 13,500 sq ft.
- Built-up area - 18,000 sq ft.
Capitalization Overview
- Has an INR 30 lakh CC limit.- Directors - 2 - stakes - 90/10.
Recent Activity
-
Earlier than 15 daysMerger And Acquisition Consultant, Chandigarh, M&A Advisor connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
1 Buyer already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 67,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses